| Selected publications: 1/. Evgeni E. Gabev, Evgeni B. Gabev, Evgeni E. Gabev, Jr., Masha V. Bogoeva. Fitting analysis provides further evidence for eradication of HIV/AIDS infection under combined liposome drug delivery treatment. Drug Delivery Systems and Sciences (UK) 2003, 3, (2): 49-51. Click here for full text (.pdf). 2/. Evgeni E. Gabev, Evgeni B. Gabev, Masha V. Bogoeva, Evgeni E. Gabev, Jr. Blocking of the polyphosphoinositide transmembrane signaling system is a novel and promising approach for AIDS therapy. European Journal of Parenteral Sciences (UK) 2002, 7, (1): 3-11). Click here for full text (pdf). 3/. Gabev EE, Kasianowicz J, Abbot T, McLaughlin S. Binding of neomycin to phosphatidylinositol 4,5-biphosphate (PIP2). Biochim Biophys Acta 1989; 979: 105-112. Medline. Click here for full text (pdf). 4/. Gabev EE, Svilenov D, Poljakova-Krusteva O, Vassilev I. Brain, liver and spleen detection of liposomes after rectal administration. J Microencapsul 1985, 2: 85-89. 5/. Bogoeva MV, Gabev E, Botev B. Effect of liposome entrapped specific cell growth inhibitor (chalone) on tumour cell proliferation. J Microencapsul 1988; 5: 59-64. 6/. Beshkov D, Gabev EE, Gabev EB, Argirova R. In vitro studies of liposome encapsulated anti HIV agents: A new approach in AIDS therapy?. Probl of Inf and Par Dis 1997; 24: 8-9. 7/. Gabev EE, Gabev EB, Mitcheva M, Astroug H, Karaivanova M. Acute toxicity study on a new liposome combination preparation. In: Abstract book, volume 1, XI International Conference on AIDS, 7-12 July, 1996, Vancouver, Canada, 1996; Tu. B. 2321. click for the Abstract here or here. 8/. Gabev EE, Gabev EB, Beshkov D, Argirova R. In vitro study of liposome encapsulated AZT and its combination with presumptive enzyme blocking agent (PEBA). In: Abstract book, volume 2, VII International Conference on AIDS, 16-21 June, 1991, Florence, Italy, 1991; W. A. 1002. |